Canaccord Genuity Boosts Target on Alexion Pharmaceuticals (ALXN) After Pipeline Analysis
Tweet Send to a Friend
Canaccord Genuity boosted its price target on Buy-rated Alexion Pharmaceuticals (NASDAQ: ALXN) from $115 to $132, saying pipeline analysis suggests ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
